Nathan A. Evans is a registered patent attorney with Woods Rogers who focuses on intellectual property (IP)—including patents, trademarks, copyrights, and trade secrets—and he assists start-ups and established companies protect and monetize their IP rights.
Based in Charlottesville, Nathan counsels clients in virtually all IP-related topics, including patent preparation and prosecution, opinions, enforcement strategies, litigation, and licensing.
He has worked on matters before state and federal district courts, the U.S. Patent & Trademark Office (including the Patent Trial and Appeal Board), the U.S. International Trade Commission, and the Court of Appeals for the Federal Circuit.
In addition to prosecuting many patent applications before the USPTO, and involvement with the post-grant review process, Nathan’s litigation experience includes cases involving the infringement, validity, and enforceability of patents covering AstraZeneca’s Crestor and Eli Lilly’s Zyprexa and Evista pharmaceuticals.
In addition to prosecution and litigation regarding chemical compounds and biotechnology, he has participated in matters involving computer software applications, medical devices, networking solutions, cellular phone technology, multilayer plastic films, paper products, pultruded and extruded structural articles, and optical discs (CDs).
Nathan has substantial experience with India’s patent laws and co-chaired an American Bar Association subcommittee on changes to Indian patent law. He also acted as a co-chair of a subcommittee of the Patent System Policy Planning Division Committee.
He now serves on the Virginia Bar Association’s IP Council and the Charlottesville Mayor’s Advisory Council on Innovation and Technology, and he is an Ambassador for the Charlottesville Chamber of Commerce.
His experience highlights include:
- Counsel for plaintiff in litigation relating to e-commerce platform. Case settled favorably. Moore & Giles, Inc. v. Landmark Technology, LLC, 6:18-cv-00052-NKM (W.D. Va. 2018)
- Counsel for plaintiff in litigation relating to medical device technology. Case settled favorably. Human Design Medical, LLC v. My Health, Inc., 1:16-cv-00767 (D. Del. 2016)
- Successfully argued patent claim construction issues in favorable Markman ruling (W.D. Va. 2015)
- Successfully helped defend lucrative electrical engineering patent and license in significant jury trial victory (S.D.N.Y. 2013)
- Eli Lilly & Co. v. Zenith Goldline Pharms., Inc. (S.D. Ind., Fed. Cir.). Helped successfully obtain determination of infringement, validity, and enforceability of an Orange Book listed patent for Eli Lilly over the drug product Zyprexa®
- Active in other successful Abbreviated New Drug Application (ANDA) patent infringement litigations defending challenges to pharmaceutical patents, including patents on Eli Lilly and Company’s Evista® pharmaceutical
- Held leadership roles at the American Bar Association, co-chairing subcommittees regarding compulsory licensing issues and changes to India’s patent law regime
Cost
Rate : $$$
